Skip to content

Test of suppression of postprandial blood glucose elevation by food ingestion

Test of suppression of postprandial blood glucose elevation by food ingestion - Test of suppression of postprandial blood glucose elevation by food ingestion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000049491
Enrollment
20
Registered
2023-10-31
Start date
2022-11-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Interventions

Single intake of test foods containing bitter gourd, etc. Single intake of placebo foods

Sponsors

Lifix Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Male and female subjects aged 20 to 64 years (2) Normal to slightly elevated fasting blood glucose level (125 mg/dL or less) at baseline (3) Subjects who give written voluntary consent to participate in the study

Exclusion criteria

Exclusion criteria: (1) Persons who are currently judged to have and treated diabetes mellitus (2) Persons who are currently receiving medication for diabetes mellitus or hypertension (3) Persons who are consuming foods or health foods containing ingredients of this experimental food (4) Persons who are regularly taking supplements related to cholesterol, blood pressure, blood lipids, blood sugar levels (5) Persons who have serious diseases related to sugar metabolism, lipid metabolism (6) Persons with serious diseases or mental disorders of liver function, renal function, heart, circulatory system, respiratory system, endocrine system, immune system, nervous system (6) Subjects with a history of abnormal laboratory values and judged to have problems in participating in the study (7) Subjects with a disease under treatment or a history of a serious disease requiring medication (8) Subjects at risk of developing allergies related to the study (9) Subjects who are not suitable as subjects based on the results of the Lifestyle Questionnaire. (10) Subjects who are participating in other clinical studies at the start of this study (11) Subjects who are pregnant or plan to become pregnant or breastfeeding during the study period (12) Subjects who are judged by the investigator (or the study administrator) to be unsuitable for study participation

Design outcomes

Primary

MeasureTime frame
Changes in postprandial blood glucose levels

Countries

Japan

Contacts

Public ContactShigefumi Nibun

EAS inc. Clinical Trial Session

info@eas-ct.jp070-5415-3051

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026